Skip to main content

Insulin Resistance Linked to Risk for More Than 30 Diseases

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 9, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, Sept. 9, 2024 -- Insulin resistance (IR) is associated with multiple systemic diseases, according a study presented at the annual meeting of the European Association for the Study of Diabetes, held from Sept. 9 to 13 in Madrid.

Jing Wu and Y. Song, from the Cheeloo College of Medicine at Shandong University in Jinan, China, explored the correlation between IR and systemic diseases using data from the U.K. Biobank, which recruited more than 500,000 participants aged 40 to 69 years. The degree of IR was measured using the triglyceride-glucose index and triglyceride/high-density lipoprotein cholesterol ratio.

The researchers identified a correlation between IR and 31 diseases (26 positive and five negative correlations) during a median follow-up of 13 years, and for all-cause mortality among women. Strong associations were seen for IR with diabetes, gout, disorders of lipoprotein metabolism, and other lipidemias. A novel finding of an association between IR and diseases such as gout, Parkinson disease, and sciatica was seen.

"We have shown that by assessing the degree of insulin resistance, it is possible to identify individuals who are at risk of developing obesity, hypertension, heart disease, gout, sciatica, and some other diseases," Wu said in a statement. "This provides a basis for early intervention measures to reduce the risk of disease and also offers new ideas for disease prevention and treatment."

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Many Medicaid Enrollees Have Restricted Access to SGLT2 Inhibitors, GLP-1 Receptor Agonists

WEDNESDAY, April 30, 2025 -- Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose cotransporter-2...

Metabolic Syndrome Linked to Increased Risk for Young-Onset Dementia

THURSDAY, April 24, 2025 -- Metabolic syndrome (MetS) and its individual components are associated with an increased risk for young-onset dementia (YOD), according to a study...

Adverse Pregnancy Outcomes Partly Mediate Association Between Prepregnancy Obesity, CVD Risk

MONDAY, April 21, 2025 -- Adverse pregnancy outcomes (APOs) mediate a small proportion of the association between prepregnancy obesity and cardiovascular disease (CVD) risk in...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.